| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Immunity, Innate | 23 | 2024 | 767 | 3.130 |
Why?
|
| Herpesvirus 1, Human | 14 | 2025 | 78 | 2.990 |
Why?
|
| Receptors, Cell Surface | 20 | 2012 | 437 | 2.260 |
Why?
|
| Interferon Type I | 14 | 2024 | 168 | 2.220 |
Why?
|
| Membrane Glycoproteins | 25 | 2019 | 670 | 2.120 |
Why?
|
| Toll-Like Receptors | 27 | 2011 | 434 | 1.630 |
Why?
|
| Toll-Like Receptor 2 | 26 | 2016 | 219 | 1.620 |
Why?
|
| Signal Transduction | 41 | 2025 | 2905 | 1.550 |
Why?
|
| Cytokines | 30 | 2022 | 915 | 1.470 |
Why?
|
| Herpes Simplex | 5 | 2017 | 49 | 1.410 |
Why?
|
| Lipopolysaccharide Receptors | 17 | 2022 | 145 | 1.310 |
Why?
|
| Toll-Like Receptor 4 | 27 | 2022 | 349 | 1.280 |
Why?
|
| Cardiovirus Infections | 3 | 2024 | 13 | 1.180 |
Why?
|
| Encephalomyocarditis virus | 3 | 2024 | 14 | 1.180 |
Why?
|
| Membrane Proteins | 11 | 2024 | 850 | 1.170 |
Why?
|
| Mice | 85 | 2025 | 10362 | 1.110 |
Why?
|
| Mice, Knockout | 47 | 2024 | 2004 | 1.110 |
Why?
|
| Macrophages | 21 | 2019 | 1017 | 1.090 |
Why?
|
| Animals | 104 | 2025 | 19839 | 1.090 |
Why?
|
| ADAM Proteins | 2 | 2024 | 35 | 1.050 |
Why?
|
| Mice, Inbred C57BL | 49 | 2025 | 3236 | 0.990 |
Why?
|
| Helicobacter pylori | 3 | 2012 | 59 | 0.980 |
Why?
|
| Interferon-Induced Helicase, IFIH1 | 3 | 2024 | 15 | 0.950 |
Why?
|
| Neutrophils | 9 | 2024 | 354 | 0.930 |
Why?
|
| Helicobacter Infections | 5 | 2012 | 56 | 0.920 |
Why?
|
| Spike Glycoprotein, Coronavirus | 2 | 2022 | 95 | 0.880 |
Why?
|
| Myeloid Differentiation Factor 88 | 14 | 2022 | 207 | 0.870 |
Why?
|
| Myocarditis | 1 | 2024 | 61 | 0.850 |
Why?
|
| Inflammasomes | 6 | 2015 | 333 | 0.680 |
Why?
|
| Interleukin-1 | 16 | 2013 | 156 | 0.660 |
Why?
|
| Virus Replication | 7 | 2015 | 308 | 0.660 |
Why?
|
| Antibodies, Neutralizing | 1 | 2021 | 192 | 0.650 |
Why?
|
| NF-kappa B | 10 | 2010 | 463 | 0.650 |
Why?
|
| Antiviral Agents | 7 | 2022 | 319 | 0.640 |
Why?
|
| Inflammation | 13 | 2019 | 1116 | 0.630 |
Why?
|
| Cell Line | 26 | 2021 | 2015 | 0.620 |
Why?
|
| DNA Viruses | 2 | 2018 | 15 | 0.610 |
Why?
|
| Hepatocytes | 9 | 2016 | 198 | 0.520 |
Why?
|
| DEAD-box RNA Helicases | 3 | 2013 | 79 | 0.520 |
Why?
|
| Viruses | 4 | 2011 | 79 | 0.510 |
Why?
|
| Phosphoproteins | 2 | 2014 | 214 | 0.510 |
Why?
|
| Antigens, Surface | 5 | 2012 | 192 | 0.510 |
Why?
|
| Leukocytes, Mononuclear | 8 | 2022 | 243 | 0.500 |
Why?
|
| Nucleotidyltransferases | 3 | 2025 | 57 | 0.500 |
Why?
|
| Humans | 72 | 2025 | 60999 | 0.490 |
Why?
|
| Monocytes | 7 | 2022 | 346 | 0.480 |
Why?
|
| Encephalitis, Herpes Simplex | 2 | 2025 | 8 | 0.470 |
Why?
|
| Interleukin-1beta | 9 | 2015 | 262 | 0.470 |
Why?
|
| RNA Viruses | 1 | 2014 | 8 | 0.460 |
Why?
|
| Lymphocytes | 3 | 2022 | 193 | 0.460 |
Why?
|
| Carrier Proteins | 8 | 2015 | 704 | 0.460 |
Why?
|
| Drosophila Proteins | 7 | 2003 | 684 | 0.440 |
Why?
|
| Lymphocytic choriomeningitis virus | 6 | 2012 | 86 | 0.430 |
Why?
|
| Ribonuclease III | 1 | 2013 | 82 | 0.430 |
Why?
|
| Toll-Like Receptor 3 | 6 | 2022 | 67 | 0.430 |
Why?
|
| Simplexvirus | 3 | 2015 | 25 | 0.430 |
Why?
|
| Ethanol | 6 | 2019 | 309 | 0.410 |
Why?
|
| Helicobacter felis | 4 | 2009 | 17 | 0.410 |
Why?
|
| Virus Diseases | 3 | 2011 | 114 | 0.400 |
Why?
|
| Encephalitis, Viral | 2 | 2020 | 5 | 0.400 |
Why?
|
| Transendothelial and Transepithelial Migration | 2 | 2024 | 12 | 0.400 |
Why?
|
| Adaptor Proteins, Signal Transducing | 8 | 2024 | 420 | 0.400 |
Why?
|
| Nuclear Proteins | 2 | 2014 | 761 | 0.400 |
Why?
|
| HEK293 Cells | 4 | 2024 | 588 | 0.390 |
Why?
|
| Lipopolysaccharides | 14 | 2015 | 635 | 0.390 |
Why?
|
| Respiratory Syncytial Virus Infections | 5 | 2022 | 34 | 0.390 |
Why?
|
| RNA, Viral | 5 | 2018 | 265 | 0.380 |
Why?
|
| Fibroblasts | 5 | 2012 | 378 | 0.380 |
Why?
|
| Blood-Brain Barrier | 2 | 2024 | 81 | 0.380 |
Why?
|
| Respiratory Syncytial Viruses | 3 | 2015 | 17 | 0.380 |
Why?
|
| Mucins | 2 | 2012 | 25 | 0.370 |
Why?
|
| Transcription, Genetic | 2 | 2014 | 848 | 0.360 |
Why?
|
| Interferon Regulatory Factor-3 | 4 | 2017 | 91 | 0.360 |
Why?
|
| Antibodies, Viral | 7 | 2021 | 304 | 0.360 |
Why?
|
| Muscle Proteins | 2 | 2012 | 111 | 0.350 |
Why?
|
| Immediate-Early Proteins | 1 | 2010 | 44 | 0.350 |
Why?
|
| Toll-Like Receptor 7 | 5 | 2019 | 97 | 0.330 |
Why?
|
| Influenza A Virus, H3N2 Subtype | 2 | 2015 | 26 | 0.330 |
Why?
|
| Central Nervous System | 1 | 2011 | 193 | 0.330 |
Why?
|
| Drosophila melanogaster | 1 | 2013 | 481 | 0.330 |
Why?
|
| Polymers | 1 | 2013 | 318 | 0.330 |
Why?
|
| Receptor, Interferon alpha-beta | 4 | 2016 | 45 | 0.320 |
Why?
|
| Cells, Cultured | 17 | 2017 | 2108 | 0.320 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2010 | 208 | 0.310 |
Why?
|
| Embryo, Mammalian | 2 | 2012 | 161 | 0.300 |
Why?
|
| Receptors, Virus | 2 | 2007 | 82 | 0.300 |
Why?
|
| Host-Pathogen Interactions | 4 | 2017 | 238 | 0.290 |
Why?
|
| Peptides | 3 | 2012 | 552 | 0.290 |
Why?
|
| Gastric Mucosa | 2 | 2009 | 53 | 0.290 |
Why?
|
| Tumor Necrosis Factor-alpha | 13 | 2022 | 589 | 0.290 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 5 | 2014 | 459 | 0.290 |
Why?
|
| Transfection | 12 | 2016 | 678 | 0.280 |
Why?
|
| Neutrophil Activation | 2 | 2008 | 24 | 0.280 |
Why?
|
| Liver Diseases, Alcoholic | 3 | 2015 | 85 | 0.280 |
Why?
|
| Interleukin-8 | 3 | 2008 | 85 | 0.280 |
Why?
|
| Caenorhabditis elegans | 1 | 2013 | 628 | 0.280 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 2008 | 73 | 0.270 |
Why?
|
| Communicable Diseases | 1 | 2007 | 85 | 0.270 |
Why?
|
| Macrophage Activation | 4 | 2010 | 119 | 0.260 |
Why?
|
| Gastrointestinal Diseases | 1 | 2006 | 77 | 0.260 |
Why?
|
| Immune Evasion | 2 | 2017 | 53 | 0.260 |
Why?
|
| Blood Platelets | 2 | 2019 | 101 | 0.250 |
Why?
|
| MicroRNAs | 3 | 2018 | 623 | 0.250 |
Why?
|
| Antigen-Presenting Cells | 6 | 2010 | 177 | 0.250 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 3 | 2015 | 87 | 0.250 |
Why?
|
| Toll-Like Receptor 9 | 6 | 2014 | 200 | 0.250 |
Why?
|
| Orthomyxoviridae Infections | 2 | 2016 | 70 | 0.250 |
Why?
|
| Macrophages, Peritoneal | 7 | 2012 | 73 | 0.240 |
Why?
|
| Disease Models, Animal | 9 | 2024 | 2083 | 0.240 |
Why?
|
| Endoplasmic Reticulum Stress | 2 | 2016 | 39 | 0.240 |
Why?
|
| Uric Acid | 2 | 2015 | 49 | 0.240 |
Why?
|
| Influenza A virus | 2 | 2019 | 117 | 0.240 |
Why?
|
| Liver | 7 | 2019 | 806 | 0.240 |
Why?
|
| Helicobacter hepaticus | 1 | 2004 | 2 | 0.240 |
Why?
|
| Zymosan | 2 | 2004 | 24 | 0.240 |
Why?
|
| Astrocytes | 2 | 2020 | 117 | 0.240 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 4 | 2013 | 27 | 0.240 |
Why?
|
| Membrane Transport Proteins | 3 | 2010 | 123 | 0.240 |
Why?
|
| Oseltamivir | 2 | 2016 | 34 | 0.240 |
Why?
|
| Interleukin-1 Receptor-Associated Kinases | 2 | 2022 | 33 | 0.230 |
Why?
|
| Interleukin-6 | 7 | 2022 | 310 | 0.230 |
Why?
|
| Microscopy, Fluorescence, Multiphoton | 1 | 2024 | 3 | 0.220 |
Why?
|
| Intravital Microscopy | 1 | 2024 | 12 | 0.220 |
Why?
|
| Influenza, Human | 2 | 2019 | 193 | 0.220 |
Why?
|
| Acute-Phase Proteins | 1 | 2004 | 34 | 0.220 |
Why?
|
| Fatty Liver, Alcoholic | 2 | 2015 | 33 | 0.220 |
Why?
|
| Chemical and Drug Induced Liver Injury | 2 | 2016 | 42 | 0.220 |
Why?
|
| Genome, Viral | 2 | 2015 | 122 | 0.220 |
Why?
|
| Adenosine Triphosphate | 2 | 2015 | 289 | 0.210 |
Why?
|
| Malaria, Falciparum | 2 | 2022 | 119 | 0.210 |
Why?
|
| Viral Fusion Proteins | 3 | 2010 | 74 | 0.210 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 6 | 2015 | 256 | 0.200 |
Why?
|
| A549 Cells | 1 | 2022 | 36 | 0.200 |
Why?
|
| Lymphocytic Choriomeningitis | 4 | 2012 | 53 | 0.200 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2022 | 42 | 0.200 |
Why?
|
| Gene Expression Regulation | 6 | 2016 | 1550 | 0.200 |
Why?
|
| Lymphocyte Antigen 96 | 5 | 2011 | 53 | 0.200 |
Why?
|
| Lymphocyte Activation | 10 | 2012 | 742 | 0.200 |
Why?
|
| Serine Endopeptidases | 1 | 2022 | 83 | 0.190 |
Why?
|
| Enterovirus B, Human | 3 | 2010 | 17 | 0.190 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 6 | 2013 | 531 | 0.190 |
Why?
|
| DNA-Binding Proteins | 5 | 2015 | 1153 | 0.190 |
Why?
|
| T-Lymphocytes | 9 | 2014 | 972 | 0.180 |
Why?
|
| Cell Fusion | 1 | 2021 | 45 | 0.180 |
Why?
|
| Vaccines, Virus-Like Particle | 1 | 2021 | 16 | 0.180 |
Why?
|
| Bone Marrow Cells | 3 | 2014 | 233 | 0.180 |
Why?
|
| Chemokine CXCL1 | 1 | 2020 | 4 | 0.180 |
Why?
|
| Viral Vaccines | 1 | 2021 | 49 | 0.180 |
Why?
|
| Inflammation Mediators | 3 | 2010 | 170 | 0.180 |
Why?
|
| Plasmodium falciparum | 2 | 2022 | 135 | 0.180 |
Why?
|
| DNA Primers | 3 | 2014 | 291 | 0.180 |
Why?
|
| Species Specificity | 3 | 2012 | 334 | 0.170 |
Why?
|
| Chaperonin 60 | 1 | 2000 | 19 | 0.170 |
Why?
|
| Respiratory Syncytial Virus Vaccines | 2 | 2010 | 20 | 0.170 |
Why?
|
| Newcastle disease virus | 2 | 2010 | 86 | 0.160 |
Why?
|
| Myelin Proteins | 2 | 2010 | 31 | 0.160 |
Why?
|
| Proteolipids | 2 | 2010 | 24 | 0.160 |
Why?
|
| Virion | 2 | 2010 | 123 | 0.160 |
Why?
|
| Myeloid Cells | 2 | 2011 | 92 | 0.160 |
Why?
|
| Stomach | 2 | 2012 | 85 | 0.160 |
Why?
|
| B-Lymphocytes | 3 | 2005 | 553 | 0.160 |
Why?
|
| Listeria monocytogenes | 4 | 2014 | 33 | 0.160 |
Why?
|
| Platelet Activation | 1 | 2019 | 32 | 0.160 |
Why?
|
| Disease Resistance | 1 | 2019 | 23 | 0.160 |
Why?
|
| In Vitro Techniques | 5 | 2013 | 476 | 0.160 |
Why?
|
| RNA, Messenger | 7 | 2013 | 1475 | 0.150 |
Why?
|
| Adipocytes | 2 | 2019 | 254 | 0.150 |
Why?
|
| Stomach Neoplasms | 2 | 2009 | 74 | 0.150 |
Why?
|
| CD4-Positive T-Lymphocytes | 4 | 2012 | 624 | 0.150 |
Why?
|
| Herpesviridae | 1 | 2018 | 14 | 0.150 |
Why?
|
| Cytomegalovirus | 2 | 2013 | 90 | 0.150 |
Why?
|
| Hepatitis | 2 | 2010 | 56 | 0.150 |
Why?
|
| Models, Biological | 5 | 2019 | 1150 | 0.150 |
Why?
|
| Microglia | 2 | 2013 | 231 | 0.150 |
Why?
|
| Receptors, Immunologic | 5 | 2005 | 180 | 0.150 |
Why?
|
| Interferon Regulatory Factor-7 | 3 | 2012 | 34 | 0.150 |
Why?
|
| DNA, Protozoan | 1 | 2017 | 36 | 0.140 |
Why?
|
| Granuloma | 2 | 2008 | 41 | 0.140 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2011 | 701 | 0.140 |
Why?
|
| Gene Expression | 4 | 2015 | 816 | 0.140 |
Why?
|
| Female | 25 | 2020 | 31733 | 0.140 |
Why?
|
| Liposomes | 2 | 2015 | 100 | 0.140 |
Why?
|
| Liver Cirrhosis | 2 | 2016 | 163 | 0.140 |
Why?
|
| Neisseria gonorrhoeae | 2 | 2017 | 233 | 0.140 |
Why?
|
| 5' Untranslated Regions | 1 | 2017 | 24 | 0.140 |
Why?
|
| CD8-Positive T-Lymphocytes | 3 | 2012 | 652 | 0.130 |
Why?
|
| Adipose Tissue | 1 | 2019 | 285 | 0.130 |
Why?
|
| Pyrophosphatases | 1 | 2016 | 11 | 0.130 |
Why?
|
| Dendritic Cells | 6 | 2013 | 509 | 0.130 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2017 | 83 | 0.130 |
Why?
|
| Dinucleoside Phosphates | 1 | 2016 | 32 | 0.130 |
Why?
|
| Nucleotides, Cyclic | 3 | 2025 | 16 | 0.130 |
Why?
|
| Mutation | 5 | 2013 | 2485 | 0.130 |
Why?
|
| Sugar Phosphates | 1 | 2016 | 3 | 0.130 |
Why?
|
| Disaccharides | 1 | 2016 | 10 | 0.130 |
Why?
|
| Recombinant Proteins | 6 | 2012 | 700 | 0.130 |
Why?
|
| Liver Diseases | 2 | 2008 | 140 | 0.130 |
Why?
|
| Toll-Like Receptor 8 | 2 | 2008 | 44 | 0.130 |
Why?
|
| Luciferases | 3 | 2012 | 110 | 0.130 |
Why?
|
| Recombinant Fusion Proteins | 5 | 2010 | 499 | 0.130 |
Why?
|
| Ligands | 3 | 2008 | 423 | 0.130 |
Why?
|
| Base Sequence | 4 | 2014 | 1310 | 0.130 |
Why?
|
| Cell Separation | 3 | 2012 | 146 | 0.130 |
Why?
|
| Streptococcus agalactiae | 1 | 2016 | 80 | 0.130 |
Why?
|
| Immunoglobulin G | 2 | 2016 | 451 | 0.130 |
Why?
|
| Genetic Vectors | 2 | 2021 | 818 | 0.130 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 2 | 2014 | 71 | 0.130 |
Why?
|
| Acute Lung Injury | 1 | 2016 | 44 | 0.130 |
Why?
|
| Chemokine CCL2 | 4 | 2013 | 54 | 0.130 |
Why?
|
| Lung | 7 | 2016 | 919 | 0.120 |
Why?
|
| Probenecid | 1 | 2015 | 6 | 0.120 |
Why?
|
| Complement Inactivating Agents | 1 | 2015 | 13 | 0.120 |
Why?
|
| Allopurinol | 1 | 2015 | 17 | 0.120 |
Why?
|
| Streptococcus pyogenes | 1 | 2015 | 27 | 0.120 |
Why?
|
| Reassortant Viruses | 1 | 2015 | 9 | 0.120 |
Why?
|
| Heparitin Sulfate | 1 | 2015 | 10 | 0.120 |
Why?
|
| Parainfluenza Virus 3, Human | 1 | 2015 | 5 | 0.120 |
Why?
|
| Up-Regulation | 5 | 2012 | 369 | 0.120 |
Why?
|
| Streptococcal Infections | 1 | 2015 | 77 | 0.120 |
Why?
|
| Evolution, Molecular | 2 | 2015 | 296 | 0.120 |
Why?
|
| Neurons | 1 | 2020 | 867 | 0.120 |
Why?
|
| Colonic Neoplasms | 2 | 2009 | 217 | 0.120 |
Why?
|
| Selection, Genetic | 1 | 2015 | 70 | 0.120 |
Why?
|
| Gene Silencing | 2 | 2014 | 381 | 0.120 |
Why?
|
| Viral Load | 2 | 2012 | 229 | 0.120 |
Why?
|
| Brain | 2 | 2013 | 1515 | 0.110 |
Why?
|
| Interleukins | 2 | 2012 | 78 | 0.110 |
Why?
|
| Antigens, Bacterial | 1 | 2015 | 198 | 0.110 |
Why?
|
| Chemokine CCL8 | 1 | 2014 | 6 | 0.110 |
Why?
|
| Receptors, Interleukin-1 | 3 | 2013 | 65 | 0.110 |
Why?
|
| Listeriosis | 1 | 2014 | 30 | 0.110 |
Why?
|
| Gene Knockdown Techniques | 1 | 2014 | 195 | 0.110 |
Why?
|
| Lymphokines | 4 | 1987 | 66 | 0.110 |
Why?
|
| Receptors, Pattern Recognition | 2 | 2011 | 31 | 0.110 |
Why?
|
| Myelin and Lymphocyte-Associated Proteolipid Proteins | 2 | 2010 | 12 | 0.110 |
Why?
|
| Mice, Transgenic | 3 | 2019 | 1227 | 0.110 |
Why?
|
| HeLa Cells | 3 | 2004 | 531 | 0.110 |
Why?
|
| Vero Cells | 4 | 2015 | 77 | 0.100 |
Why?
|
| Orexin Receptors | 1 | 2012 | 2 | 0.100 |
Why?
|
| Polymerase Chain Reaction | 1 | 2014 | 499 | 0.100 |
Why?
|
| Cerebellum | 1 | 2013 | 93 | 0.100 |
Why?
|
| Endothelium, Vascular | 3 | 1989 | 172 | 0.100 |
Why?
|
| Membrane Microdomains | 1 | 2013 | 48 | 0.100 |
Why?
|
| Sialic Acids | 1 | 2013 | 39 | 0.100 |
Why?
|
| DNA | 2 | 2015 | 810 | 0.100 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2013 | 124 | 0.100 |
Why?
|
| Encephalitis | 1 | 2012 | 33 | 0.100 |
Why?
|
| Permeability | 2 | 2024 | 48 | 0.100 |
Why?
|
| Gene Targeting | 1 | 2012 | 80 | 0.100 |
Why?
|
| Interleukin-10 | 2 | 2011 | 149 | 0.100 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2014 | 215 | 0.100 |
Why?
|
| Capsid | 1 | 2013 | 89 | 0.100 |
Why?
|
| Dietary Fats | 2 | 2012 | 205 | 0.100 |
Why?
|
| Hookworm Infections | 1 | 2012 | 10 | 0.100 |
Why?
|
| Herpes Labialis | 1 | 2011 | 3 | 0.100 |
Why?
|
| Drug Resistance, Viral | 1 | 2013 | 158 | 0.100 |
Why?
|
| Surface Properties | 1 | 2013 | 274 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 21 | 1 | 2011 | 27 | 0.100 |
Why?
|
| Adrenal Glands | 1 | 2012 | 32 | 0.100 |
Why?
|
| DNA, Viral | 1 | 2013 | 228 | 0.100 |
Why?
|
| Cytoskeletal Proteins | 1 | 2013 | 197 | 0.100 |
Why?
|
| Virulence | 2 | 2015 | 189 | 0.100 |
Why?
|
| Thrombosis | 1 | 2014 | 191 | 0.100 |
Why?
|
| Dissection | 1 | 2012 | 44 | 0.100 |
Why?
|
| Protein Transport | 2 | 2011 | 399 | 0.100 |
Why?
|
| Histocompatibility Antigens Class II | 4 | 2008 | 180 | 0.100 |
Why?
|
| Virus Physiological Phenomena | 1 | 2011 | 7 | 0.090 |
Why?
|
| Phagocytosis | 1 | 2013 | 252 | 0.090 |
Why?
|
| Trefoil Factor-2 | 2 | 2012 | 6 | 0.090 |
Why?
|
| Polysaccharides | 1 | 2013 | 147 | 0.090 |
Why?
|
| Antibodies | 2 | 2011 | 180 | 0.090 |
Why?
|
| Male | 16 | 2019 | 28463 | 0.090 |
Why?
|
| Lung Injury | 2 | 2009 | 33 | 0.090 |
Why?
|
| Particle Size | 1 | 2013 | 400 | 0.090 |
Why?
|
| Respiratory Syncytial Virus, Human | 3 | 2022 | 22 | 0.090 |
Why?
|
| Liver Cirrhosis, Experimental | 1 | 2011 | 4 | 0.090 |
Why?
|
| Flow Cytometry | 6 | 2010 | 642 | 0.090 |
Why?
|
| Osteolysis | 1 | 2010 | 17 | 0.090 |
Why?
|
| Antigens, Viral | 1 | 2011 | 133 | 0.090 |
Why?
|
| Toxoplasmosis, Animal | 1 | 2010 | 10 | 0.090 |
Why?
|
| Cell Culture Techniques | 1 | 2012 | 179 | 0.090 |
Why?
|
| Apoptosis | 2 | 2013 | 1044 | 0.090 |
Why?
|
| Antigens, CD | 3 | 2010 | 344 | 0.090 |
Why?
|
| Genes, Viral | 1 | 2010 | 56 | 0.090 |
Why?
|
| Viral Envelope Proteins | 1 | 2011 | 111 | 0.090 |
Why?
|
| Antigens, Differentiation | 3 | 2005 | 141 | 0.090 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2010 | 30 | 0.090 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 2 | 1987 | 109 | 0.090 |
Why?
|
| Alcoholism | 1 | 2013 | 311 | 0.090 |
Why?
|
| Titanium | 1 | 2010 | 58 | 0.090 |
Why?
|
| Glycoproteins | 1 | 2011 | 192 | 0.080 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2010 | 107 | 0.080 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2010 | 66 | 0.080 |
Why?
|
| Gene Expression Profiling | 2 | 2018 | 721 | 0.080 |
Why?
|
| Immunologic Factors | 1 | 2010 | 100 | 0.080 |
Why?
|
| Interferon-gamma | 6 | 2010 | 551 | 0.080 |
Why?
|
| T-Box Domain Proteins | 1 | 2009 | 41 | 0.080 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2011 | 478 | 0.080 |
Why?
|
| Homeostasis | 1 | 2012 | 346 | 0.080 |
Why?
|
| fas Receptor | 1 | 2009 | 54 | 0.080 |
Why?
|
| Pancreatitis, Acute Necrotizing | 1 | 2009 | 25 | 0.080 |
Why?
|
| Arenaviridae Infections | 1 | 2008 | 14 | 0.080 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2010 | 194 | 0.080 |
Why?
|
| Gastritis | 1 | 2008 | 17 | 0.080 |
Why?
|
| Glucose | 1 | 2012 | 449 | 0.080 |
Why?
|
| TNF Receptor-Associated Factor 6 | 1 | 2008 | 23 | 0.080 |
Why?
|
| Homeodomain Proteins | 1 | 2010 | 257 | 0.080 |
Why?
|
| Blotting, Western | 4 | 2014 | 596 | 0.080 |
Why?
|
| Dogs | 3 | 2015 | 314 | 0.080 |
Why?
|
| Phosphorylation | 3 | 2017 | 882 | 0.080 |
Why?
|
| Chemokines | 2 | 2008 | 94 | 0.070 |
Why?
|
| Cricetinae | 4 | 2005 | 376 | 0.070 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2010 | 303 | 0.070 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 1988 | 67 | 0.070 |
Why?
|
| Macrolides | 1 | 2008 | 38 | 0.070 |
Why?
|
| Lymphotoxin-alpha | 1 | 1987 | 8 | 0.070 |
Why?
|
| Genes, Reporter | 3 | 2010 | 244 | 0.070 |
Why?
|
| Corneal Stroma | 1 | 2007 | 7 | 0.070 |
Why?
|
| Keratitis | 1 | 2007 | 9 | 0.070 |
Why?
|
| Capsid Proteins | 1 | 2008 | 93 | 0.070 |
Why?
|
| Genes, p53 | 1 | 2007 | 53 | 0.070 |
Why?
|
| Cell Cycle Proteins | 1 | 2010 | 389 | 0.070 |
Why?
|
| Immunity, Active | 1 | 2007 | 10 | 0.070 |
Why?
|
| Transplantation Tolerance | 1 | 2007 | 65 | 0.070 |
Why?
|
| Virus Activation | 1 | 2007 | 24 | 0.070 |
Why?
|
| Drug Evaluation, Preclinical | 3 | 2013 | 96 | 0.070 |
Why?
|
| Rhabdoviridae Infections | 1 | 2007 | 5 | 0.070 |
Why?
|
| Vesicular stomatitis Indiana virus | 1 | 2007 | 16 | 0.070 |
Why?
|
| Asthma | 1 | 2012 | 463 | 0.070 |
Why?
|
| Promoter Regions, Genetic | 1 | 2010 | 664 | 0.070 |
Why?
|
| Toll-Like Receptor 1 | 2 | 2004 | 22 | 0.070 |
Why?
|
| Virus Internalization | 1 | 2008 | 99 | 0.070 |
Why?
|
| Killer Cells, Natural | 2 | 2006 | 216 | 0.070 |
Why?
|
| Point Mutation | 1 | 2007 | 162 | 0.070 |
Why?
|
| Skin Transplantation | 1 | 2007 | 155 | 0.070 |
Why?
|
| Tumor Cells, Cultured | 3 | 2009 | 457 | 0.070 |
Why?
|
| Plasma Cells | 1 | 2007 | 49 | 0.070 |
Why?
|
| Polymorphism, Genetic | 1 | 2007 | 195 | 0.070 |
Why?
|
| Muromegalovirus | 1 | 2006 | 7 | 0.070 |
Why?
|
| Liver Neoplasms | 1 | 2009 | 278 | 0.070 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 2 | 2022 | 83 | 0.070 |
Why?
|
| Adenocarcinoma | 1 | 2009 | 332 | 0.070 |
Why?
|
| Herpesviridae Infections | 1 | 2006 | 28 | 0.070 |
Why?
|
| Cytoplasmic Vesicles | 1 | 2006 | 7 | 0.060 |
Why?
|
| CHO Cells | 3 | 2005 | 191 | 0.060 |
Why?
|
| Neutrophil Infiltration | 2 | 2020 | 61 | 0.060 |
Why?
|
| Propionibacterium | 1 | 2005 | 5 | 0.060 |
Why?
|
| Insulin Resistance | 1 | 2009 | 409 | 0.060 |
Why?
|
| Transcription Factors | 1 | 2014 | 1486 | 0.060 |
Why?
|
| Herpesvirus 3, Human | 1 | 2005 | 9 | 0.060 |
Why?
|
| Herpes Zoster | 1 | 2005 | 24 | 0.060 |
Why?
|
| Intestines | 1 | 2006 | 156 | 0.060 |
Why?
|
| Microscopy, Confocal | 3 | 2015 | 222 | 0.060 |
Why?
|
| Recurrence | 1 | 2007 | 608 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2006 | 296 | 0.060 |
Why?
|
| Gram-Positive Bacterial Infections | 1 | 2005 | 30 | 0.060 |
Why?
|
| Antigen Presentation | 1 | 2007 | 229 | 0.060 |
Why?
|
| Molecular Chaperones | 1 | 2006 | 99 | 0.060 |
Why?
|
| Herpesvirus 2, Human | 1 | 2005 | 10 | 0.060 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2007 | 484 | 0.060 |
Why?
|
| Kidney | 2 | 2004 | 420 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2004 | 831 | 0.060 |
Why?
|
| Viral Core Proteins | 1 | 2004 | 30 | 0.060 |
Why?
|
| Intestinal Mucosa | 1 | 2006 | 226 | 0.060 |
Why?
|
| HMGB1 Protein | 2 | 2016 | 26 | 0.060 |
Why?
|
| Interferons | 1 | 2005 | 63 | 0.060 |
Why?
|
| Adult | 5 | 2019 | 16226 | 0.060 |
Why?
|
| Muscle, Skeletal | 1 | 2009 | 681 | 0.060 |
Why?
|
| Primary Cell Culture | 2 | 2015 | 76 | 0.060 |
Why?
|
| Burns | 1 | 2004 | 42 | 0.060 |
Why?
|
| Polymyxin B | 1 | 2004 | 7 | 0.060 |
Why?
|
| Toll-Like Receptor 5 | 1 | 2004 | 11 | 0.060 |
Why?
|
| Viral Nonstructural Proteins | 1 | 2004 | 93 | 0.050 |
Why?
|
| Immunoprecipitation | 2 | 2014 | 115 | 0.050 |
Why?
|
| Drug Combinations | 1 | 2004 | 156 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 4 | 2008 | 668 | 0.050 |
Why?
|
| Streptolysins | 1 | 2003 | 8 | 0.050 |
Why?
|
| Culture Media, Conditioned | 2 | 2015 | 51 | 0.050 |
Why?
|
| Hepacivirus | 1 | 2004 | 140 | 0.050 |
Why?
|
| Nucleoproteins | 2 | 2015 | 31 | 0.050 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2014 | 194 | 0.050 |
Why?
|
| Mice, Inbred A | 3 | 1988 | 20 | 0.050 |
Why?
|
| Pneumococcal Infections | 1 | 2003 | 36 | 0.050 |
Why?
|
| Schistosoma mansoni | 1 | 2002 | 6 | 0.050 |
Why?
|
| Cell Membrane | 4 | 2003 | 495 | 0.050 |
Why?
|
| Choline Deficiency | 2 | 2014 | 14 | 0.050 |
Why?
|
| Lysophospholipids | 1 | 2002 | 23 | 0.050 |
Why?
|
| Cell Communication | 2 | 2015 | 127 | 0.050 |
Why?
|
| Methionine | 2 | 2014 | 55 | 0.050 |
Why?
|
| Adjuvants, Immunologic | 1 | 2004 | 228 | 0.050 |
Why?
|
| Golgi Apparatus | 1 | 2002 | 64 | 0.050 |
Why?
|
| Host-Parasite Interactions | 1 | 2002 | 55 | 0.050 |
Why?
|
| Cell Line, Tumor | 3 | 2011 | 1389 | 0.050 |
Why?
|
| Escherichia coli | 2 | 2004 | 693 | 0.050 |
Why?
|
| Wounds and Injuries | 1 | 2004 | 244 | 0.050 |
Why?
|
| Interleukin-18 | 3 | 2008 | 74 | 0.050 |
Why?
|
| Genotype | 2 | 2015 | 652 | 0.050 |
Why?
|
| Receptors, Interleukin-8B | 1 | 2020 | 1 | 0.040 |
Why?
|
| Acyclovir | 1 | 2020 | 20 | 0.040 |
Why?
|
| Triglycerides | 2 | 2013 | 244 | 0.040 |
Why?
|
| Age Factors | 1 | 2005 | 1549 | 0.040 |
Why?
|
| Infant, Newborn | 1 | 2005 | 1326 | 0.040 |
Why?
|
| I-kappa B Proteins | 1 | 2000 | 39 | 0.040 |
Why?
|
| Reactive Oxygen Species | 2 | 2013 | 202 | 0.040 |
Why?
|
| Chlamydia | 1 | 2000 | 10 | 0.040 |
Why?
|
| HN Protein | 2 | 2010 | 57 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 2 | 2003 | 862 | 0.040 |
Why?
|
| Mice, Mutant Strains | 2 | 2010 | 303 | 0.040 |
Why?
|
| Immunization | 2 | 2010 | 132 | 0.040 |
Why?
|
| Interferon-beta | 2 | 2013 | 77 | 0.040 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 2 | 1989 | 12 | 0.040 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2000 | 77 | 0.040 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2000 | 127 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2010 | 219 | 0.040 |
Why?
|
| Endotoxins | 1 | 2000 | 78 | 0.040 |
Why?
|
| Models, Animal | 2 | 2011 | 223 | 0.040 |
Why?
|
| Enzyme Activation | 1 | 2000 | 359 | 0.040 |
Why?
|
| Interleukin-2 | 3 | 1991 | 165 | 0.040 |
Why?
|
| Complement C3 | 1 | 2019 | 60 | 0.040 |
Why?
|
| Middle Aged | 4 | 2019 | 16872 | 0.040 |
Why?
|
| Fatty Liver | 2 | 2011 | 97 | 0.040 |
Why?
|
| Extracellular Traps | 1 | 2019 | 40 | 0.040 |
Why?
|
| Gene Knockout Techniques | 1 | 2019 | 88 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2000 | 206 | 0.040 |
Why?
|
| Bone Marrow | 2 | 2010 | 175 | 0.040 |
Why?
|
| GTP-Binding Proteins | 1 | 1998 | 80 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 3 | 2009 | 879 | 0.040 |
Why?
|
| Genetic Testing | 1 | 2019 | 132 | 0.040 |
Why?
|
| Cell Nucleus | 2 | 2013 | 607 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 1 | 2004 | 748 | 0.040 |
Why?
|
| Shock, Septic | 1 | 1998 | 90 | 0.040 |
Why?
|
| Phenotype | 2 | 2011 | 1158 | 0.040 |
Why?
|
| Adenoviruses, Human | 1 | 1997 | 9 | 0.040 |
Why?
|
| Chromatin | 1 | 2022 | 603 | 0.030 |
Why?
|
| Antibodies, Anti-Idiotypic | 2 | 1988 | 34 | 0.030 |
Why?
|
| Carbon Tetrachloride | 1 | 2016 | 9 | 0.030 |
Why?
|
| Disease Susceptibility | 2 | 2007 | 159 | 0.030 |
Why?
|
| Plasmids | 2 | 2011 | 284 | 0.030 |
Why?
|
| Erythrocytes | 1 | 2017 | 155 | 0.030 |
Why?
|
| Biotransformation | 1 | 2016 | 23 | 0.030 |
Why?
|
| Insulin | 2 | 2012 | 695 | 0.030 |
Why?
|
| Bacterial Secretion Systems | 1 | 2016 | 10 | 0.030 |
Why?
|
| Antigen-Antibody Complex | 2 | 2007 | 50 | 0.030 |
Why?
|
| Interleukin-12 | 2 | 2010 | 122 | 0.030 |
Why?
|
| Interferon-alpha | 2 | 2007 | 99 | 0.030 |
Why?
|
| Interleukin-1 Receptor Accessory Protein | 1 | 2016 | 1 | 0.030 |
Why?
|
| Microbial Viability | 1 | 2016 | 55 | 0.030 |
Why?
|
| Cell Movement | 2 | 2010 | 428 | 0.030 |
Why?
|
| Orthomyxoviridae | 1 | 2016 | 26 | 0.030 |
Why?
|
| Cellular Microenvironment | 1 | 2015 | 20 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2017 | 188 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2016 | 134 | 0.030 |
Why?
|
| Cell Proliferation | 2 | 2010 | 948 | 0.030 |
Why?
|
| Iron | 1 | 2016 | 139 | 0.030 |
Why?
|
| Antimetabolites | 1 | 2015 | 17 | 0.030 |
Why?
|
| Adjuvants, Pharmaceutic | 1 | 2015 | 7 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2019 | 5288 | 0.030 |
Why?
|
| Influenza A Virus, H1N2 Subtype | 1 | 2015 | 6 | 0.030 |
Why?
|
| Molecular Targeted Therapy | 1 | 2016 | 120 | 0.030 |
Why?
|
| Madin Darby Canine Kidney Cells | 1 | 2015 | 22 | 0.030 |
Why?
|
| Complement Activation | 1 | 2015 | 49 | 0.030 |
Why?
|
| Limit of Detection | 1 | 2015 | 43 | 0.030 |
Why?
|
| Gene Frequency | 1 | 2015 | 132 | 0.030 |
Why?
|
| DNA, Bacterial | 1 | 2016 | 260 | 0.030 |
Why?
|
| Hemagglutinin Glycoproteins, Influenza Virus | 1 | 2015 | 40 | 0.030 |
Why?
|
| Gonorrhea | 1 | 2017 | 180 | 0.030 |
Why?
|
| Mice, Inbred C3H | 2 | 2003 | 175 | 0.030 |
Why?
|
| Bacterial Outer Membrane Proteins | 1 | 2015 | 121 | 0.030 |
Why?
|
| Platelet Count | 1 | 2014 | 25 | 0.030 |
Why?
|
| Spleen | 2 | 2006 | 485 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2016 | 565 | 0.030 |
Why?
|
| Cell Degranulation | 1 | 2014 | 20 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 2 | 2008 | 355 | 0.030 |
Why?
|
| Secretory Vesicles | 1 | 2014 | 22 | 0.030 |
Why?
|
| Positive Regulatory Domain I-Binding Factor 1 | 1 | 2014 | 8 | 0.030 |
Why?
|
| Viral Plaque Assay | 1 | 2013 | 16 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2015 | 160 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2015 | 297 | 0.030 |
Why?
|
| Interleukin-4 | 3 | 1991 | 144 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2014 | 218 | 0.030 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 2014 | 54 | 0.030 |
Why?
|
| RNA, Small Interfering | 2 | 2013 | 857 | 0.030 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2013 | 90 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2015 | 263 | 0.030 |
Why?
|
| Cytotoxicity, Immunologic | 2 | 2001 | 145 | 0.030 |
Why?
|
| Hemagglutination | 1 | 2013 | 3 | 0.030 |
Why?
|
| Rous sarcoma virus | 1 | 2013 | 3 | 0.030 |
Why?
|
| Sendai virus | 1 | 2013 | 13 | 0.030 |
Why?
|
| Acetylation | 1 | 2013 | 113 | 0.030 |
Why?
|
| High-Throughput Screening Assays | 1 | 2013 | 74 | 0.030 |
Why?
|
| CARD Signaling Adaptor Proteins | 1 | 2013 | 64 | 0.030 |
Why?
|
| Protein Binding | 2 | 2011 | 1585 | 0.030 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2013 | 30 | 0.030 |
Why?
|
| Receptors, Interleukin-1 Type I | 1 | 2012 | 9 | 0.030 |
Why?
|
| Computational Biology | 1 | 2015 | 340 | 0.030 |
Why?
|
| Interleukin-1alpha | 1 | 2012 | 25 | 0.030 |
Why?
|
| Kupffer Cells | 1 | 2012 | 42 | 0.030 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2013 | 149 | 0.030 |
Why?
|
| Ubiquitination | 1 | 2013 | 107 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2013 | 500 | 0.020 |
Why?
|
| Nippostrongylus | 1 | 2012 | 2 | 0.020 |
Why?
|
| Interleukin-33 | 1 | 2012 | 18 | 0.020 |
Why?
|
| Caspase 1 | 1 | 2012 | 110 | 0.020 |
Why?
|
| Cytosol | 1 | 2013 | 171 | 0.020 |
Why?
|
| Immunity, Mucosal | 1 | 2012 | 48 | 0.020 |
Why?
|
| Fasting | 1 | 2012 | 53 | 0.020 |
Why?
|
| Genetic Linkage | 1 | 2011 | 92 | 0.020 |
Why?
|
| Th2 Cells | 1 | 2012 | 98 | 0.020 |
Why?
|
| Antigen-Antibody Reactions | 1 | 2011 | 12 | 0.020 |
Why?
|
| Macrophages, Alveolar | 1 | 2012 | 59 | 0.020 |
Why?
|
| Glucose Tolerance Test | 1 | 2012 | 99 | 0.020 |
Why?
|
| Immunization, Passive | 2 | 1989 | 102 | 0.020 |
Why?
|
| Adaptive Immunity | 1 | 2012 | 94 | 0.020 |
Why?
|
| Haplotypes | 1 | 2011 | 122 | 0.020 |
Why?
|
| Receptors, Transferrin | 1 | 2011 | 33 | 0.020 |
Why?
|
| Adiposity | 1 | 2012 | 81 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2011 | 119 | 0.020 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 2011 | 8 | 0.020 |
Why?
|
| Obesity | 1 | 2019 | 1218 | 0.020 |
Why?
|
| Thiobarbituric Acid Reactive Substances | 1 | 2011 | 16 | 0.020 |
Why?
|
| Hypoglycemia | 1 | 2012 | 68 | 0.020 |
Why?
|
| Transferrin | 1 | 2011 | 67 | 0.020 |
Why?
|
| Alanine Transaminase | 1 | 2011 | 39 | 0.020 |
Why?
|
| Skin | 3 | 1989 | 355 | 0.020 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2011 | 28 | 0.020 |
Why?
|
| Lipid Peroxidation | 1 | 2011 | 64 | 0.020 |
Why?
|
| NADPH Oxidases | 1 | 2011 | 65 | 0.020 |
Why?
|
| Clone Cells | 2 | 1987 | 106 | 0.020 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2011 | 54 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 2011 | 285 | 0.020 |
Why?
|
| Genes, APC | 1 | 2010 | 10 | 0.020 |
Why?
|
| DEAD Box Protein 58 | 1 | 2010 | 18 | 0.020 |
Why?
|
| Fatty Acids | 1 | 2012 | 196 | 0.020 |
Why?
|
| COS Cells | 1 | 2010 | 176 | 0.020 |
Why?
|
| Collagen | 1 | 2011 | 118 | 0.020 |
Why?
|
| Crosses, Genetic | 1 | 2010 | 105 | 0.020 |
Why?
|
| Toxoplasma | 1 | 2010 | 32 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 2013 | 381 | 0.020 |
Why?
|
| Epithelium | 1 | 2010 | 97 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2010 | 189 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2010 | 162 | 0.020 |
Why?
|
| Stromal Cells | 1 | 2010 | 65 | 0.020 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2010 | 37 | 0.020 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2010 | 47 | 0.020 |
Why?
|
| Transcription Factor RelA | 1 | 2010 | 49 | 0.020 |
Why?
|
| Body Weight | 1 | 2012 | 389 | 0.020 |
Why?
|
| Coxsackievirus Infections | 1 | 2010 | 12 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2013 | 757 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2010 | 225 | 0.020 |
Why?
|
| Mammary Glands, Animal | 1 | 2010 | 78 | 0.020 |
Why?
|
| Creatine Kinase | 1 | 2009 | 43 | 0.020 |
Why?
|
| Mice, Inbred CBA | 2 | 1986 | 83 | 0.020 |
Why?
|
| CASP8 and FADD-Like Apoptosis Regulating Protein | 1 | 2009 | 9 | 0.020 |
Why?
|
| Glucose Clamp Technique | 1 | 2009 | 58 | 0.020 |
Why?
|
| Hyperinsulinism | 1 | 2009 | 25 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2009 | 43 | 0.020 |
Why?
|
| Aged | 2 | 2019 | 13876 | 0.020 |
Why?
|
| Lipids | 1 | 2012 | 307 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2010 | 178 | 0.020 |
Why?
|
| Fas Ligand Protein | 1 | 2009 | 39 | 0.020 |
Why?
|
| Diet | 1 | 2014 | 650 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2009 | 94 | 0.020 |
Why?
|
| Actins | 1 | 2011 | 260 | 0.020 |
Why?
|
| Ceruletide | 1 | 2009 | 5 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2010 | 513 | 0.020 |
Why?
|
| H(+)-K(+)-Exchanging ATPase | 1 | 2008 | 1 | 0.020 |
Why?
|
| Mice, Inbred NOD | 1 | 2010 | 517 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2011 | 285 | 0.020 |
Why?
|
| Propionibacterium acnes | 1 | 2008 | 6 | 0.020 |
Why?
|
| Cytochrome P-450 CYP2E1 | 1 | 2008 | 9 | 0.020 |
Why?
|
| Cell Adhesion | 2 | 1989 | 208 | 0.020 |
Why?
|
| Chimera | 1 | 2008 | 42 | 0.020 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2008 | 101 | 0.020 |
Why?
|
| NADP | 1 | 2008 | 24 | 0.020 |
Why?
|
| Haptens | 1 | 1988 | 13 | 0.020 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2010 | 202 | 0.020 |
Why?
|
| Viral Proteins | 1 | 2010 | 261 | 0.020 |
Why?
|
| Arginine | 1 | 2009 | 114 | 0.020 |
Why?
|
| Immunoglobulin M | 1 | 1988 | 114 | 0.020 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2008 | 44 | 0.020 |
Why?
|
| Precancerous Conditions | 1 | 2008 | 72 | 0.020 |
Why?
|
| Receptors, Interleukin-4 | 1 | 1987 | 8 | 0.020 |
Why?
|
| Receptors, Mitogen | 1 | 1987 | 6 | 0.020 |
Why?
|
| Interferon Inducers | 1 | 2007 | 11 | 0.020 |
Why?
|
| Fibrosarcoma | 1 | 2007 | 13 | 0.020 |
Why?
|
| Multiple Sclerosis | 1 | 1991 | 209 | 0.020 |
Why?
|
| Stimulation, Chemical | 1 | 1987 | 18 | 0.020 |
Why?
|
| Poly I-C | 1 | 2007 | 76 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2007 | 97 | 0.020 |
Why?
|
| Time Factors | 2 | 2007 | 3663 | 0.020 |
Why?
|
| Young Adult | 1 | 2017 | 4433 | 0.020 |
Why?
|
| Culture Media | 1 | 1987 | 77 | 0.020 |
Why?
|
| Bone Marrow Transplantation | 1 | 2007 | 139 | 0.020 |
Why?
|
| Proteome | 1 | 2008 | 143 | 0.020 |
Why?
|
| Transplantation, Homologous | 1 | 2007 | 246 | 0.020 |
Why?
|
| Receptors, Fc | 1 | 2007 | 21 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2009 | 860 | 0.020 |
Why?
|
| Growth Substances | 1 | 1987 | 35 | 0.020 |
Why?
|
| Epitopes | 1 | 1988 | 294 | 0.020 |
Why?
|
| Immunity, Cellular | 1 | 1987 | 176 | 0.020 |
Why?
|
| Adolescent | 1 | 2017 | 6044 | 0.020 |
Why?
|
| Graft Survival | 1 | 2007 | 291 | 0.020 |
Why?
|
| Injections, Intraperitoneal | 1 | 1986 | 46 | 0.020 |
Why?
|
| Respiratory Tract Infections | 1 | 2007 | 85 | 0.020 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2007 | 196 | 0.020 |
Why?
|
| Lymphocyte Count | 1 | 2006 | 71 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2007 | 178 | 0.020 |
Why?
|
| Peritoneal Cavity | 1 | 1985 | 31 | 0.020 |
Why?
|
| Binding Sites | 1 | 2008 | 895 | 0.020 |
Why?
|
| Liver Failure, Acute | 1 | 2005 | 16 | 0.020 |
Why?
|
| Leukocytes | 1 | 2004 | 98 | 0.010 |
Why?
|
| Intracellular Fluid | 1 | 2003 | 32 | 0.010 |
Why?
|
| Extracellular Space | 1 | 2003 | 31 | 0.010 |
Why?
|
| Hepatitis C, Chronic | 1 | 2004 | 88 | 0.010 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2003 | 65 | 0.010 |
Why?
|
| Brefeldin A | 1 | 2002 | 8 | 0.010 |
Why?
|
| Hepatitis C | 1 | 2004 | 143 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2002 | 79 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2009 | 683 | 0.010 |
Why?
|
| Luminescent Proteins | 1 | 2002 | 129 | 0.010 |
Why?
|
| Survival Rate | 1 | 2004 | 812 | 0.010 |
Why?
|
| Child | 1 | 2012 | 4384 | 0.010 |
Why?
|
| Prognosis | 1 | 2006 | 1631 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2010 | 1133 | 0.010 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 2002 | 244 | 0.010 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2001 | 169 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2002 | 399 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 2002 | 197 | 0.010 |
Why?
|
| NF-KappaB Inhibitor alpha | 1 | 2000 | 26 | 0.010 |
Why?
|
| gamma-Globulins | 2 | 1989 | 10 | 0.010 |
Why?
|
| Wasp Venoms | 1 | 1998 | 2 | 0.010 |
Why?
|
| Virulence Factors, Bordetella | 1 | 1998 | 14 | 0.010 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 1998 | 154 | 0.010 |
Why?
|
| Coxsackie and Adenovirus Receptor-Like Membrane Protein | 1 | 1997 | 1 | 0.010 |
Why?
|
| Cytopathogenic Effect, Viral | 1 | 1997 | 11 | 0.010 |
Why?
|
| Bacterial Proteins | 1 | 2003 | 736 | 0.010 |
Why?
|
| Calcium | 1 | 2000 | 560 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 1997 | 294 | 0.010 |
Why?
|
| Rats | 1 | 1998 | 1930 | 0.010 |
Why?
|
| Gene Transfer Techniques | 1 | 1997 | 307 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 1997 | 1578 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 1997 | 1976 | 0.010 |
Why?
|
| Lymphocyte Culture Test, Mixed | 1 | 1991 | 33 | 0.010 |
Why?
|
| Lymphocyte Depletion | 1 | 1991 | 98 | 0.010 |
Why?
|
| Transforming Growth Factor beta | 1 | 1991 | 165 | 0.010 |
Why?
|
| E-Selectin | 1 | 1989 | 18 | 0.010 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 1989 | 53 | 0.010 |
Why?
|
| HLA-DQ Antigens | 1 | 1989 | 14 | 0.010 |
Why?
|
| Cell Adhesion Molecules | 1 | 1989 | 85 | 0.010 |
Why?
|
| Listeria | 1 | 1985 | 11 | 0.000 |
Why?
|
| Child, Preschool | 1 | 1989 | 1881 | 0.000 |
Why?
|
| Immunosuppressive Agents | 1 | 1985 | 370 | 0.000 |
Why?
|